WEC
GH icon

Winslow Evans & Crocker’s Guardant Health GH Stock Holding History

Winslow Evans & Crocker’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$16K Hold
122
– – ﹤0.01% 844
2020
Q3 		$14K Hold
122
– – ﹤0.01% 686
2020
Q2 		$10K Buy
122
+22
+22% +$1.77K ﹤0.01% 736
2020
Q1 		$8K Hold
100
– – ﹤0.01% 751
2019
Q4 		$8K Hold
100
– – ﹤0.01% 868
2019
Q3 		$8K Hold
100
– – ﹤0.01% 861
2019
Q2 		$10K Hold
100
– – ﹤0.01% 821
2019
Q1 		$8K Buy
+100
New +$5.54K ﹤0.01% 862

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Winslow Evans & Crocker's GH Position: Q4 2020 in Review

Winslow Evans & Crocker held its Guardant Health (GH) position steady in Q4 2020 at 122 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Winslow Evans & Crocker first reported a position in GH in Q1 2019 and has held it in 8 quarters since. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

  • Winslow Evans & Crocker held 122 shares of Guardant Health worth $16K as of Q4 2020.
  • Winslow Evans & Crocker left its Guardant Health share count unchanged in Q4 2020.
  • Guardant Health made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #844 holding.
  • Winslow Evans & Crocker first reported a position in Guardant Health in Q1 2019 and has held it in 8 quarters since.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.